DK1027325T3 - Lipofile diestere af cheleringsmidler - Google Patents
Lipofile diestere af cheleringsmidlerInfo
- Publication number
- DK1027325T3 DK1027325T3 DK98946694T DK98946694T DK1027325T3 DK 1027325 T3 DK1027325 T3 DK 1027325T3 DK 98946694 T DK98946694 T DK 98946694T DK 98946694 T DK98946694 T DK 98946694T DK 1027325 T3 DK1027325 T3 DK 1027325T3
- Authority
- DK
- Denmark
- Prior art keywords
- diesters
- chelating agents
- condition
- divalent metal
- metal ions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/76—Metal complexes of amino carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Steroid Compounds (AREA)
- Fats And Perfumes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12184497A IL121844A0 (en) | 1997-09-28 | 1997-09-28 | Lipophilic diesters of chelating agents |
| PCT/IL1998/000468 WO1999016741A2 (en) | 1997-09-28 | 1998-09-27 | Lipophilic diesters of chelating agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1027325T3 true DK1027325T3 (da) | 2003-07-21 |
Family
ID=11070677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98946694T DK1027325T3 (da) | 1997-09-28 | 1998-09-27 | Lipofile diestere af cheleringsmidler |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6458837B1 (hu) |
| EP (1) | EP1027325B1 (hu) |
| JP (1) | JP4668411B2 (hu) |
| KR (1) | KR100545487B1 (hu) |
| AT (1) | ATE235457T1 (hu) |
| AU (1) | AU739835B2 (hu) |
| BR (1) | BR9814053B1 (hu) |
| CA (1) | CA2304700C (hu) |
| CZ (1) | CZ300455B6 (hu) |
| DE (1) | DE69812679T2 (hu) |
| DK (1) | DK1027325T3 (hu) |
| ES (1) | ES2195393T3 (hu) |
| HU (1) | HU229161B1 (hu) |
| IL (2) | IL121844A0 (hu) |
| NZ (1) | NZ503085A (hu) |
| PT (1) | PT1027325E (hu) |
| WO (1) | WO1999016741A2 (hu) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6350780B1 (en) * | 1995-07-28 | 2002-02-26 | Allergan Sales, Inc. | Methods and compositions for drug delivery |
| WO2001041756A2 (en) * | 1999-12-02 | 2001-06-14 | University Of South Florida | Method and composition for treatment of ischemic neuronal reperfusion injury |
| AUPS255402A0 (en) * | 2002-05-27 | 2002-06-13 | Monash University | Agents and methods for the treatment of disorders associated with oxidative stress |
| IL151921A0 (en) * | 2002-09-25 | 2003-04-10 | Pharma Ltd D | Liphopilic diesters of chelating agent for inhibition of enzyme activity |
| IL157396A0 (en) * | 2003-08-14 | 2004-02-19 | Dpharm Ltd | Use of lipophilic diesters of chelating agent for the treatment of amyloidosis and atherosclerosis |
| WO2008099210A2 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
| GB0708507D0 (en) | 2007-05-02 | 2007-06-13 | Queen Mary & Westfield College | Substituted phosphonates and their use |
| CN102093234B (zh) * | 2009-11-26 | 2014-06-18 | 福州乾正药业有限公司 | 一种二元酯酸的氨丁三醇盐化合物及其制备方法和药物应用 |
| WO2013052787A2 (en) * | 2011-10-05 | 2013-04-11 | The Johns Hopkins University | Membrane activated chelators and use in the prevention and treatment of parasitic infection |
| CN103373957A (zh) * | 2012-04-12 | 2013-10-30 | 成都苑东药业有限公司 | 一种具有神经细胞保护作用的螯合物 |
| WO2015092789A1 (en) * | 2013-12-17 | 2015-06-25 | D-Pharm Ltd. | Onium salts of lipophilic diesters of chelating agents |
| CN107315915A (zh) * | 2017-06-28 | 2017-11-03 | 上海联影医疗科技有限公司 | 一种医疗手术模拟方法及系统 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3479535A (en) * | 1966-11-23 | 1969-11-18 | Us Army | Symmetrical pulse generator controlled by self-resetting snap diodes |
| US3497535A (en) | 1967-07-25 | 1970-02-24 | Geigy Chem Corp | Stabilization of fats and oils with esters of edta and related compounds |
| US3751440A (en) * | 1971-08-30 | 1973-08-07 | Ciba Geigy Corp | Metal complexes of n,n-dialkylesters of ethylenedinitrilotetraacetic acid and and compositions stabilized thereby |
| JPS5867652A (ja) * | 1981-10-16 | 1983-04-22 | Dai Ichi Pure Chem Co Ltd | エチレンジアミン四酢酸−ｎ，ｎ′−ジ（２−エチルヘキシル）エステル |
| JPS59168442A (ja) * | 1983-03-16 | 1984-09-22 | Fuji Photo Film Co Ltd | 画像形成方法 |
| US4603161A (en) * | 1985-06-14 | 1986-07-29 | Olin Corporation | Selected oxyalkylated 2,6-dialkylphenol compounds and their use as stabilizers of organic materials against oxidative degradation |
| US4849362A (en) * | 1988-05-19 | 1989-07-18 | Smithkline Beckman Corporation | Fluorescent intracellular calcium indicators |
| US5453517A (en) * | 1992-02-25 | 1995-09-26 | Molecular Probes, Inc. | Reactive derivatives of bapta used to make ion-selective chelators |
| US6015834A (en) * | 1992-10-20 | 2000-01-18 | Toronto Neuroprotection Group | In vivo treatment of mammalian cells with a cell membrane permeant calcium buffer |
| US5618513A (en) * | 1995-06-07 | 1997-04-08 | Mallinckrodt Medical, Inc. | Method for preparing radiolabeled peptides |
-
1997
- 1997-09-28 IL IL12184497A patent/IL121844A0/xx unknown
-
1998
- 1998-09-27 CZ CZ20001065A patent/CZ300455B6/cs not_active IP Right Cessation
- 1998-09-27 WO PCT/IL1998/000468 patent/WO1999016741A2/en active IP Right Grant
- 1998-09-27 ES ES98946694T patent/ES2195393T3/es not_active Expired - Lifetime
- 1998-09-27 AU AU93651/98A patent/AU739835B2/en not_active Ceased
- 1998-09-27 US US09/509,393 patent/US6458837B1/en not_active Expired - Lifetime
- 1998-09-27 EP EP98946694A patent/EP1027325B1/en not_active Expired - Lifetime
- 1998-09-27 DE DE69812679T patent/DE69812679T2/de not_active Expired - Lifetime
- 1998-09-27 PT PT98946694T patent/PT1027325E/pt unknown
- 1998-09-27 CA CA2304700A patent/CA2304700C/en not_active Expired - Lifetime
- 1998-09-27 JP JP2000513827A patent/JP4668411B2/ja not_active Expired - Fee Related
- 1998-09-27 KR KR1020007003280A patent/KR100545487B1/ko not_active IP Right Cessation
- 1998-09-27 HU HU0003517A patent/HU229161B1/hu not_active IP Right Cessation
- 1998-09-27 BR BRPI9814053-1A patent/BR9814053B1/pt not_active IP Right Cessation
- 1998-09-27 AT AT98946694T patent/ATE235457T1/de active
- 1998-09-27 NZ NZ503085A patent/NZ503085A/xx not_active IP Right Cessation
- 1998-09-27 DK DK98946694T patent/DK1027325T3/da active
-
2000
- 2000-03-15 IL IL135097A patent/IL135097A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010015634A (ko) | 2001-02-26 |
| HUP0003517A2 (hu) | 2001-02-28 |
| IL135097A (en) | 2009-09-01 |
| JP4668411B2 (ja) | 2011-04-13 |
| DE69812679D1 (de) | 2003-04-30 |
| DE69812679T2 (de) | 2004-03-04 |
| ES2195393T3 (es) | 2003-12-01 |
| WO1999016741A2 (en) | 1999-04-08 |
| BR9814053B1 (pt) | 2010-11-30 |
| CZ300455B6 (cs) | 2009-05-20 |
| BR9814053A (pt) | 2000-09-26 |
| HU229161B1 (en) | 2013-09-30 |
| NZ503085A (en) | 2002-09-27 |
| JP2001518458A (ja) | 2001-10-16 |
| HUP0003517A3 (en) | 2003-06-30 |
| CA2304700A1 (en) | 1999-04-08 |
| AU739835B2 (en) | 2001-10-18 |
| AU9365198A (en) | 1999-04-23 |
| CZ20001065A3 (cs) | 2000-08-16 |
| EP1027325B1 (en) | 2003-03-26 |
| ATE235457T1 (de) | 2003-04-15 |
| KR100545487B1 (ko) | 2006-01-24 |
| CA2304700C (en) | 2010-10-26 |
| PT1027325E (pt) | 2003-08-29 |
| US6458837B1 (en) | 2002-10-01 |
| EP1027325A2 (en) | 2000-08-16 |
| WO1999016741A3 (en) | 1999-07-01 |
| IL121844A0 (en) | 1998-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| DE69434431D1 (de) | Methoden zur behandlung von muskelerkrankungen und muskelstörungen | |
| DK1027325T3 (da) | Lipofile diestere af cheleringsmidler | |
| DE69520768T2 (de) | Pharmazeutische Zubereitungen, die Fluoxetin enthalten | |
| EP0444196A4 (en) | Agent for treatment and prophylaxis of ischemic disease of heart or brain | |
| DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| ATE374029T1 (de) | Behandlung der alzheimer-krankheit durch erhöhung des cytidin-spiegels in vivo | |
| HUP0105027A2 (hu) | N-Heterociklusos vegyületek karbonsavszármazékai és karbonsav-izoszterei és alkalmazásuk | |
| RU95106821A (ru) | Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения | |
| TNSN98127A1 (fr) | Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| ATE179888T1 (de) | Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure | |
| HUP0100024A3 (en) | Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient | |
| EP1485096A4 (en) | METHODS FOR PREVENTING OR TREATING HEART ARRHYTHMIA | |
| MX9603300A (es) | Derivados de la 4-sulfonilbenzoilguanidina o la 4-sulfinilbenzoilguanidina. | |
| GR3025568T3 (en) | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia. | |
| RU94011321A (ru) | Способ профилактики и лечения заболеваний кожи | |
| DE69621786T2 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
| DE69626916D1 (de) | Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten | |
| ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| RU97112616A (ru) | Лекарственный препарат для лечения проктологических заболеваний | |
| RU96113804A (ru) | Лекарственное средство для лечения эпилепсии | |
| IT1271674B (it) | Composizione per uso cosmetico includente oligoelementi | |
| YU9099A (en) | Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producting a pharmaceutical preparation for treatment of the alzheimer's disease | |
| RU95104302A (ru) | Аппликационный материал лечебно-профилактического назначения | |
| TH34644A (th) | การใช้อนุพันธ์ราพามัยซินในอาการทางหลอดโลหิตจากการปลูกถ่ายอวัยวะหรือเนื้อเยื่อ |